Related Experiment Videos
Clinical trials of natural surfactant extract in respiratory distress syndrome
1Department of Pediatrics, University of Vermont, Burlington.
Insights
Natural surfactant extract significantly benefits premature infants with respiratory distress syndrome (RDS). Meta-analysis confirms clinical advantages for both prevention and treatment strategies in high-risk newborns.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Biochemistry
Background:
- Respiratory Distress Syndrome (RDS) is a critical condition in premature infants.
- Natural surfactant extract, pioneered by Fujiwara, offers a therapeutic approach.
- Previous clinical trials have investigated surfactant administration strategies.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials on natural surfactant extract for RDS.
- To evaluate the efficacy of prophylactic and rescue surfactant administration.
- To determine the overall clinical benefits of surfactant therapy.
Main Methods:
- Meta-analysis of data from multiple randomized controlled clinical trials.
- Inclusion of over 2500 infants in the analyzed trials.
- Categorization of trials into prophylactic (prevention) and rescue (treatment) groups.
Main Results:
- Significant positive effects of natural surfactant extracts were observed.
- Demonstrated significant clinical benefits in premature infants with RDS.
- Consistent advantages noted across both prevention and treatment trial data.
Conclusions:
- Natural surfactant extract therapy provides significant clinical benefits for premature infants with RDS.
- Both prophylactic and rescue administration strategies are effective.
- Meta-analysis supports the widespread use of surfactant therapy in neonatology.
Abstract:
Since the first use of natural surfactant extract by Fujiwara to treat premature infants with respiratory distress syndrome (RDS), multiple randomized controlled clinical trials involving more than 2500 infants have been reported. These trials have used prophylactic administration of surfactant to high-risk premature infants (prevention trials) or administration of surfactant to premature infants with moderate to severe RDS (rescue or treatment trials). This article shows meta-analysis of the trial data, significant effects of natural surfactant extracts, and significant clinical benefits.